英文字典中文字典


英文字典中文字典51ZiDian.com



中文字典辞典   英文字典 a   b   c   d   e   f   g   h   i   j   k   l   m   n   o   p   q   r   s   t   u   v   w   x   y   z       







请输入英文单字，中文词皆可：


请选择你想看的字典辞典：
单词字典翻译
refunding查看　refunding　在百度字典中的解释百度英翻中〔查看〕
refunding查看　refunding　在Google字典中的解释Google英翻中〔查看〕
refunding查看　refunding　在Yahoo字典中的解释Yahoo英翻中〔查看〕

安装中文字典英文字典查询工具!


中文字典英文字典工具:
选择颜色:
输入中英文单字

































































英文字典中文字典相关资料:


  • Diabetes drugs and weight loss - Mayo Clinic
    Benefits beyond weight loss Along with helping to control blood sugar and boosting weight loss, GLP-1 agonists and SGLT-2 inhibitors seem to have other health benefits Research has found that some of these medicines may lower the risk of certain serious health conditions, such as kidney disease, heart disease, heart failure and stroke
  • Prescription weight-loss drugs - Mayo Clinic
    How well do weight-loss drugs work? Prescription weight-loss drugs that you can use for more than 12 weeks lead to major weight loss compared with treatment that has no active medicine, called a placebo Weight-loss medicine and lifestyle changes lead to greater weight loss than lifestyle changes alone
  • Semaglutide (subcutaneous route) - Side effects dosage
    Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist Semaglutide injection is also used together with diet and exercise to help lose weight and keep the weight off in patients with at least one weight-related medical condition
  • Tirzepatide (subcutaneous route) - Side effects dosage
    It is used together with diet and exercise to help control your blood sugar Tirzepatide is a glucose-dependent insulinotropic polypeptide (GIP) receptor and glucagon-like peptide-1 (GLP-1) receptor agonist Tirzepatide injection is also used to help lose weight and keep the weight off in patients with obesity caused by certain conditions
  • Use of weight-loss pharmacotherapy in patients with cirrhosis and in . . .
    There are separate care pathways for patients with a class A and class B CPS and for patients with a class C CPS In addition, the authors provide an algorithmic approach to these agents in the transplant population, focusing on first line use of glucagon-like peptide 1 (GLP-1) agonists due to their additional benefits in glucose management
  • Semaglutide (oral route) - Side effects dosage - Mayo Clinic
    Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist Semaglutide is also used together with diet and exercise to help lose weight and keep the weight off in patients with at least one weight-related medical condition This medicine is available only with your doctor's prescription This product is available in the following dosage
  • Alli weight-loss pill: Does it work? - Mayo Clinic
    Alli is an over-the-counter weight-loss pill that keeps your body from absorbing all of the fat in food Learn about the drug's benefits and side effects
  • Liraglutide (subcutaneous route) - Side effects dosage
    This medicine is a glucagon-like peptide-1 (GLP-1) receptor agonist Liraglutide injection is also used together with a reduced-calorie diet and proper exercise to help patients with obesity lose weight
  • Medicamentos para la diabetes y pérdida de peso - Mayo Clinic
    Hay dos grupos principales de medicamentos para la diabetes tipo 2 que reducen la glucosa en la sangre y también pueden derivar en la pérdida de peso En el primer grupo están los agonistas del péptido similar al glucagón de tipo 1 (GLP-1, por sus siglas en inglés) En el segundo grupo están los inhibidores del cotransportador de sodio y glucosa de tipo 2 (SGLT-2, por sus siglas en
  • Complex bariatric surgery for high-risk patients and . . . - Mayo Clinic
    Despite the increased demand for glucagon-like peptide-1 receptor agonists (GLP-1 RAs), surgical procedures will continue to play a vital role in medical weight loss The field of bariatric surgery also includes higher level care to address complex needs This care is typically available only at specialized centers





中文字典-英文字典  2005-2009